| Dr Kristin Kimberly Dascomb, MD | |
|
5121 Cottonwood St, Murray, UT 84107-5701 | |
| (801) 507-4602 | |
| Not Available |
| Full Name | Dr Kristin Kimberly Dascomb |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 5121 Cottonwood St, Murray, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861688939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 6300240-1205 (Utah) | Primary |
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
As part of a 40-site national trial, researchers at UT Southwestern Medical Center are studying a new medical device designed to treat patients with chronic congestive heart failure.
According to a new study leading a healthy lifestyle can help prevent Alzheimer's disease. Researchers said at Alzheimer's Association International Conference in Paris on Tuesday that the number of Alzheimer's cases could be cut in half if people exercise, eat well and stop smoking. Other risks include depression, high blood pressure, diabetes and obesity. Education is also a factor, because illiteracy keeps brains from developing properly. The new findings have been published in the journal Lancet Neurology.
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
A new study by Johns Hopkins researchers suggests that a specialized area of the mosquito brain mixes tastes with smells to create unique and preferred flavors. The findings advance the possibility, they say, of identifying a substance that makes "human flavor" repulsive to the malaria-bearing species of the mosquitoes, so instead of feasting on us, they keep the disease to themselves, potentially saving an estimated 450,000 lives a year worldwide.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristin Kimberly Dascomb, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 507-4602 | Dr Kristin Kimberly Dascomb, MD 5121 Cottonwood St, Murray, UT 84107-5701 Ph: (801) 507-4602 |
News Archive
As part of a 40-site national trial, researchers at UT Southwestern Medical Center are studying a new medical device designed to treat patients with chronic congestive heart failure.
According to a new study leading a healthy lifestyle can help prevent Alzheimer's disease. Researchers said at Alzheimer's Association International Conference in Paris on Tuesday that the number of Alzheimer's cases could be cut in half if people exercise, eat well and stop smoking. Other risks include depression, high blood pressure, diabetes and obesity. Education is also a factor, because illiteracy keeps brains from developing properly. The new findings have been published in the journal Lancet Neurology.
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
A new study by Johns Hopkins researchers suggests that a specialized area of the mosquito brain mixes tastes with smells to create unique and preferred flavors. The findings advance the possibility, they say, of identifying a substance that makes "human flavor" repulsive to the malaria-bearing species of the mosquitoes, so instead of feasting on us, they keep the disease to themselves, potentially saving an estimated 450,000 lives a year worldwide.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
› Verified 6 days ago
Bogdan Ciprian Anea, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: Intermountain Kidney Services Clinic, 5169 South Cottonwood Street, Suite 320, Murray, UT 84107 Phone: 801-507-2531 Fax: 801-507-2597 | |
E Dennis Genebach, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5801 Fashion Blvd, Murray, UT 84107 Phone: 801-314-4544 | |
Dr. Samuel Morris Brown, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-6415 | |
Dr. Jamie Lynn Rebman, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5121 Cottonwood Rd, Suite 610, Murray, UT 84107 Phone: 801-507-3630 Fax: 801-507-3630 | |
Dr. Kia Afshar, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5169 S Cottonwood St Ste 520, Murray, UT 84107 Phone: 801-507-4701 | |
Rachel Elizabeth Hu, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3900 Fax: 801-507-3640 | |
Caroline Nebhan, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 610, Murray, UT 84107 Phone: 801-507-3630 |